Franklin Resources’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Sell
13,343
-20,864
-61% -$2.09M ﹤0.01% 2181
2026
Q1
$2.3M Buy
34,207
+4,899
+17% +$363K ﹤0.01% 1870
2025
Q4
$2.32M Buy
29,308
+12,144
+71% +$827K ﹤0.01% 1719
2025
Q3
$578K Sell
17,164
-5,006
-23% -$123K ﹤0.01% 2362
2025
Q2
$316K Buy
+22,170
New +$287K ﹤0.01% 2542
2024
Q3
Sell
-22,577
Closed -$320K 2972
2024
Q2
$320K Buy
+22,577
New +$353K ﹤0.01% 2413

Other funds holding INBX

Franklin Resources's INBX Position: Q2 2026 in Review

Franklin Resources reduced its Inhibrx (INBX) stake by 61% in Q2 2026, selling an estimated $2.09M and leaving 13,343 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2181.

Franklin Resources first reported a position in INBX in Q2 2024 and has held it in 6 quarters since. The position peaked at $2.32M in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Franklin Resources held 13,343 shares of Inhibrx worth $1.26M as of Q2 2026.
  • Franklin Resources sold 20,864 Inhibrx shares in Q2 2026, an estimated $2.09M.
  • Inhibrx made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2181 holding.
  • Franklin Resources first reported a position in Inhibrx in Q2 2024 and has held it in 6 quarters since.
  • Franklin Resources's Inhibrx position peaked at $2.32M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.